Morbihan disease: a therapeutic challenge

Detalhes bibliográficos
Autor(a) principal: Cabral,Fernanda
Data de Publicação: 2017
Outros Autores: Lubbe,Lara Caroline, Nóbrega,Monisa Martins, Obadia,Daniel Lago, Souto,Roberto, Gripp,Alexandre Carlos
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000600847
Resumo: Abstract: Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually.
id SBD-1_9d6a704eacb1fe8e20ed80dd1c421764
oai_identifier_str oai:scielo:S0365-05962017000600847
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Morbihan disease: a therapeutic challengeGlucocorticoidsIsotretinoinLymphedemaRosaceaAbstract: Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually.Sociedade Brasileira de Dermatologia2017-12-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000600847Anais Brasileiros de Dermatologia v.92 n.6 2017reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20174485info:eu-repo/semantics/openAccessCabral,FernandaLubbe,Lara CarolineNóbrega,Monisa MartinsObadia,Daniel LagoSouto,RobertoGripp,Alexandre Carloseng2018-01-19T00:00:00Zoai:scielo:S0365-05962017000600847Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2018-01-19T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Morbihan disease: a therapeutic challenge
title Morbihan disease: a therapeutic challenge
spellingShingle Morbihan disease: a therapeutic challenge
Cabral,Fernanda
Glucocorticoids
Isotretinoin
Lymphedema
Rosacea
title_short Morbihan disease: a therapeutic challenge
title_full Morbihan disease: a therapeutic challenge
title_fullStr Morbihan disease: a therapeutic challenge
title_full_unstemmed Morbihan disease: a therapeutic challenge
title_sort Morbihan disease: a therapeutic challenge
author Cabral,Fernanda
author_facet Cabral,Fernanda
Lubbe,Lara Caroline
Nóbrega,Monisa Martins
Obadia,Daniel Lago
Souto,Roberto
Gripp,Alexandre Carlos
author_role author
author2 Lubbe,Lara Caroline
Nóbrega,Monisa Martins
Obadia,Daniel Lago
Souto,Roberto
Gripp,Alexandre Carlos
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Cabral,Fernanda
Lubbe,Lara Caroline
Nóbrega,Monisa Martins
Obadia,Daniel Lago
Souto,Roberto
Gripp,Alexandre Carlos
dc.subject.por.fl_str_mv Glucocorticoids
Isotretinoin
Lymphedema
Rosacea
topic Glucocorticoids
Isotretinoin
Lymphedema
Rosacea
description Abstract: Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually.
publishDate 2017
dc.date.none.fl_str_mv 2017-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000600847
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000600847
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/abd1806-4841.20174485
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.92 n.6 2017
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126422240985088